CoChat

Endocardial Fibroelastosis Is Caused by Aberrant Endothelial to Mesenchymal Transition

Open access
Xu, Xingbo, Friehs, Ingeborg, Zhong Hu, Tachi, Melnychenko, Ivan, Tampe, Björn, Alnour, Fouzi, Iascone, Maria, Kalluri, Raghu, Zeisberg, Michael, del Nido, Pedro J., Zeisberg, Elisabeth M. · 2015 · Circulation Research
Cited by 137

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Rationale: Endocardial fibroelastosis (EFE) is a unique form of fibrosis, which forms a de novo subendocardial tissue layer encapsulating the myocardium and stunting its growth, and which is typically associated with congenital heart diseases of heterogeneous origin, such as hypoplastic left heart syndrome. Relevance of EFE was only recently highlighted through the establishment of staged biventricular repair surgery in infant patients with hypoplastic left heart syndrome, where surgical removal of EFE tissue has resulted in improvement in the restrictive physiology leading to the growth of the left ventricle in parallel with somatic growth. However, pathomechanisms underlying EFE formation are still scarce, and specific therapeutic targets are not yet known. Objective: Here, we aimed to investigate the cellular origins of EFE tissue and to gain insights into the underlying molecular mechanisms to ultimately develop novel therapeutic strategies. Methods and Results: By utilizing a novel EFE model of heterotopic transplantation of hearts from newborn reporter mice and by analyzing human EFE tissue, we demonstrate for the first time that fibrogenic cells within EFE tissue originate from endocardial endothelial cells via aberrant endothelial to mesenchymal transition. We further demonstrate that such aberrant endothelial to mesenchymal transition involving endocardial endothelial cells is caused by dysregulated transforming growth factor beta/bone morphogenetic proteins signaling and that this imbalance is at least in part caused by aberrant promoter methylation and subsequent transcriptional suppression of bone morphogenetic proteins 5 and 7. Finally, we provide evidence that supplementation of exogenous recombinant bone morphogenetic proteins 7 effectively ameliorates endothelial to mesenchymal transition and experimental EFE in rats. Conclusions: In summary, our data point to aberrant endothelial to mesenchymal transition as a common denominator of infant EFE development in heterogeneous, congenital heart diseases, and to bone morphogenetic proteins 7 as an effective treatment for EFE and its restriction of heart growth.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circresaha.116.305629

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 137

Metadata

Authors
Xu, X., Friehs, I., Zhong Hu, T., Melnychenko, I., Tampe, B., Alnour, F., Iascone, M., Kalluri, R., Zeisberg, M., del Nido, P. J., & Zeisberg, E. M.
Venue
Circulation Research
Published
2015-02-27
Volume
116
Issue
5
Pages
857-866
ISSN
  • 0009-7330 (ISSN-L)
  • 1524-4571
OpenAlex
W2131977410
Cited by
137
References
4
FWCI
5.92
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endocardial Fibroelastosis Is Caused by Aberrant Endothelial to Mesenchymal Transition. https://app.cochat.ai/papers/10.1161/circresaha.116.305629
The paper
Xu, X., Friehs, I., Zhong Hu, T., Melnychenko, I., Tampe, B., Alnour, F., Iascone, M., Kalluri, R., Zeisberg, M., del Nido, P. J., & Zeisberg, E. M. (2015). Endocardial Fibroelastosis Is Caused by Aberrant Endothelial to Mesenchymal Transition. Circulation Research. https://doi.org/10.1161/circresaha.116.305629

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.